Poor glycemic control has challenged acromegaly diagnosis due to low/normal IGF-1 level in 2 case studies; similarly to “wild-type” T2DM, IGF-1 also increases post insulin-treatment [102, 103] in secondary DM. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.